WallStreetZenWallStreetZen

NASDAQ: IMRX
Immuneering Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

IMRX past revenue growth

How has IMRX's revenue growth performed historically?
Company
-100%
Industry
148.97%
Market
17.57%
IMRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IMRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

IMRX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$53.5M
Current Profit Margin
0%

IMRX Return on Equity

Current Company
-52.5%
Current Industry
-63.5%
Current Market
188%
IMRX's Return on Equity (-52.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IMRX announces earnings.

IMRX Return on Assets

Current Company
-47.6%
Current Industry
2.9%
IMRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IMRX Return on Capital Employed

Current Company
-56.44%
Current Industry
19.5%
IMRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IMRX$0.00-$52.71M-$53.47M-100.00%N/A
GNTA$0.00-$12.28M-$12.66MN/AN/A
AVRO$0.00$12.64M$12.16MN/AN/A
INTS$0.00-$10.09M-$11.86MN/AN/A
VAXX$0.00-$54.00M-$56.93M-100.00%N/A
View Top Biotech Stocks

IMRX earnings dates

Next earnings date
May 7, 2024

Immuneering Earnings & Revenue FAQ

What were IMRX's earnings last quarter?

On Invalid Date, Immuneering (NASDAQ: IMRX) reported Q4 2023 earnings per share (EPS) of -$0.52, up 4% year over year. Total Immuneering earnings for the quarter were -$15.08 million. In the same quarter last year, Immuneering's earnings per share (EPS) was -$0.50.

If you're new to stock investing, here's how to buy Immuneering stock.

What was IMRX's earnings growth in the past year?

As of Q2 2024, Immuneering's earnings has grown year over year. Immuneering's earnings in the past year totalled -$53.47 million.

What is IMRX's earnings date?

Immuneering's earnings date is Invalid Date. Add IMRX to your watchlist to be reminded of IMRX's next earnings announcement.

What was IMRX's revenue last quarter?

On Invalid Date, Immuneering (NASDAQ: IMRX) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Immuneering's revenue was $455.00.

What was IMRX's revenue growth in the past year?

As of Q2 2024, Immuneering's revenue has grown -100% year over year. This is 248.97 percentage points lower than the US Biotechnology industry revenue growth rate of 148.97%. Immuneering's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.